Chronology of the temporal land use diversity of the study area with sampling locations. by Emmanuel Amoakwah (13228938)

PI(4,5)P₂ interacts with RalF_Rt and mediates <i>R</i>. <i>typhi</i> infection. by Kristen E. Rennoll-Bankert (785434)

“…<p>(A) RalF_RtCTD co-localizes with PI(4,5)P₂. …”

image4_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

“…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8⁺ T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”

image1_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

“…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8⁺ T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”

Table_2_The temperature-dependent expression of type II secretion system controls extracellular product secretion and virulence in mesophilic Aeromonas salmonida SRW-OG1.docx by Xin Yi (180644)

“…In this study, by constructing the mutants of tatA, tatB, and tatC, we investigated the mechanisms underlying temperature-dependent virulence regulation in mesophilic A. salmonida SRW-OG1. …”

image3_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

“…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8⁺ T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”

image4_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

“…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8⁺ T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”

datasheet1_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.docx by Victor Manuel Ruiz-Rodríguez (9704699)

“…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8⁺ T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”

image3_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

“…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8⁺ T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”

datasheet1_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.docx by Victor Manuel Ruiz-Rodríguez (9704699)

“…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8⁺ T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”

image1_Chemoresistance in Breast Cancer Patients Associated With Changes in P2X7 and A2A Purinergic Receptors in CD8+ T Lymphocytes.jpeg by Victor Manuel Ruiz-Rodríguez (9704699)

“…In this sense, as the chemotherapeutic treatment stimulates immune system response, we evaluated the expression and function of P2X7 and A2A receptors in CD8⁺ T cells before and four months after BRCA patients received neoadjuvant chemotherapy. …”

Image4_Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways.JPEG by Jia-jia Xu (10966923)

“…Hence, the aim of the present study was to investigate the effect of loganin on Ang II–induced cardiac hypertrophy. In the present study, we reported for the first time that loganin inhibits Ang II–provoked cardiac hypertrophy and cardiac damages in H9C2 cells and in mice. …”

Image1_Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways.JPEG by Jia-jia Xu (10966923)

“…Hence, the aim of the present study was to investigate the effect of loganin on Ang II–induced cardiac hypertrophy. In the present study, we reported for the first time that loganin inhibits Ang II–provoked cardiac hypertrophy and cardiac damages in H9C2 cells and in mice. …”

Image3_Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways.JPEG by Jia-jia Xu (10966923)

“…Hence, the aim of the present study was to investigate the effect of loganin on Ang II–induced cardiac hypertrophy. In the present study, we reported for the first time that loganin inhibits Ang II–provoked cardiac hypertrophy and cardiac damages in H9C2 cells and in mice. …”

Table1_Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways.DOCX by Jia-jia Xu (10966923)

“…Hence, the aim of the present study was to investigate the effect of loganin on Ang II–induced cardiac hypertrophy. In the present study, we reported for the first time that loganin inhibits Ang II–provoked cardiac hypertrophy and cardiac damages in H9C2 cells and in mice. …”

Table2_Ectopic expression of SARS-CoV-2 S and ORF-9B proteins alters metabolic profiles and impairs contractile function in cardiomyocytes.xlsx by Peng Zhang (2071)

“…<p>Coronavirus disease 2019 (COVID-19) is associated with adverse impacts in the cardiovascular system, but the mechanisms driving this response remain unclear. In this study, we conducted “pseudoviral infection” of SARS-CoV-2 subunits to evaluate their toxic effects in cardiomyocytes (CMs), that were derived from human induced pluripotent stem cells (hiPSCs). …”

Invasion assay. by Vinayaga S. Gnanapragassam (620080)

“…<p>CIM plate upper chamber was coated with ECM protein for 4 h and the SHSY5Y cells were cultured in the presence or absence of 10 mM ManNAc, ManNProp or ManNPent followed by (A) monitoring the impedance for 24 h. …”

The Mucin MUC4 and Its Membrane Partner ErbB2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells <em>via</em> Different Signalling Pathways by Nicolas Jonckheere (180288)

“…Using co-immunoprecipitation and GST pull-down, we show that MUC4 and ErbB2 interact in the human pancreatic adenocarcinomatous cell line CAPAN-2 <em>via</em> the EGF domains of MUC4. …”

Brain Water Content. by Lu Xu (386491)

Neutralization of JRFL WT and mutant viruses by different MAbs and CD4-IgG2. by Chitra Upadhyay (817121)

“…B) JRFL WT and mutant neutralization by MAbs targeting V2i, V3, V2q, and the CD4bs and by CD-IgG2. AUC values that decreased by >30% and had p<0.05 relative to WT are shown in red. …”